-
Je něco špatně v tomto záznamu ?
MPO (Myeloperoxidase) Reduces Endothelial Glycocalyx Thickness Dependent on Its Cationic Charge
K. Manchanda, H. Kolarova, C. Kerkenpaß, M. Mollenhauer, J. Vitecek, V. Rudolph, L. Kubala, S. Baldus, M. Adam, A. Klinke,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Free Medical Journals
od 1981 do Před 1 rokem
Freely Accessible Science Journals
od 1995
Open Access Digital Library
od 1981-01-01
Open Access Digital Library
od 1981-01-01
- MeSH
- aktivace neutrofilů MeSH
- břišní svaly krevní zásobení MeSH
- CHO buňky MeSH
- Cricetulus MeSH
- endoteliální buňky pupečníkové žíly (lidské) účinky léků metabolismus patologie MeSH
- endoteliální buňky účinky léků metabolismus patologie MeSH
- glykokalyx účinky léků metabolismus patologie MeSH
- heparansulfát proteoglykany metabolismus MeSH
- kationty MeSH
- lidé MeSH
- myši inbrední C57BL MeSH
- myši knockoutované MeSH
- neutrofily účinky léků metabolismus MeSH
- peroxidasa nedostatek genetika metabolismus farmakologie MeSH
- syndekan-1 metabolismus MeSH
- vazba proteinů MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Objective- The leukocyte heme-enzyme MPO (myeloperoxidase) exerts proinflammatory effects on the vascular system primarily linked to its catalytic properties. Recent studies have shown that MPO, depending on its cationic charge, mediates neutrophil recruitment and activation. Here, we further investigated MPO's extracatalytic properties and its effect on endothelial glycocalyx (EG) integrity. Approach and Results- In vivo staining of murine cremaster muscle vessels with Alcian Blue 8GX provided evidence of an MPO-dependent decrease in anionic charge of the EG. MPO binding to the glycocalyx was further characterized using Chinese hamster ovary cells and its glycosaminoglycan mutants-pgsA-745 (mutant Chinese hamster ovary cells lacking heparan sulfate and chondroitin sulfate glycosaminoglycan) and pgsD-677 (mutant Chinese hamster ovary cells lacking heparan sulfate glycosaminoglycan), which revealed heparan sulfate as the main mediator of MPO binding. Further, EG integrity was assessed in terms of thickness using intravital microscopy of murine cremaster muscle. A significant reduction in EG thickness was observed on infusion of catalytically active MPO, as well as mutant inactive MPO and cationic polymer polylysine. Similar effects were also observed in wild-type mice after a local inflammatory stimulus but not in MPO-knockout mice. The reduction in EG thickness was reversed after removal of vessel-bound MPO, suggesting a possible physical collapse of the EG. Last, experiments with in vivo neutrophil depletion revealed that MPO also induced neutrophil-mediated shedding of the EG core protein, Sdc1 (syndecan-1). Conclusions- These findings provide evidence that MPO, via ionic interaction with heparan sulfate side chains, can cause neutrophil-dependent Sdc1 shedding and collapse of the EG structure.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19035187
- 003
- CZ-PrNML
- 005
- 20191010104611.0
- 007
- ta
- 008
- 191007s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1161/ATVBAHA.118.311143 $2 doi
- 035 __
- $a (PubMed)29903730
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Manchanda, Kashish $u From the Department of Cardiology, Heart Center, University of Cologne, Germany (K.M., C.K., M.M., V.R., S.B., M.A., A.K.). Center for Molecular Medicine Cologne, University of Cologne, Germany (K.M., C.K., M.M., V.R., S.B., M.A., A.K.). Cologne Cardiovascular Research Center, University of Cologne, Germany (K.M., S.B., A.K.).
- 245 10
- $a MPO (Myeloperoxidase) Reduces Endothelial Glycocalyx Thickness Dependent on Its Cationic Charge / $c K. Manchanda, H. Kolarova, C. Kerkenpaß, M. Mollenhauer, J. Vitecek, V. Rudolph, L. Kubala, S. Baldus, M. Adam, A. Klinke,
- 520 9_
- $a Objective- The leukocyte heme-enzyme MPO (myeloperoxidase) exerts proinflammatory effects on the vascular system primarily linked to its catalytic properties. Recent studies have shown that MPO, depending on its cationic charge, mediates neutrophil recruitment and activation. Here, we further investigated MPO's extracatalytic properties and its effect on endothelial glycocalyx (EG) integrity. Approach and Results- In vivo staining of murine cremaster muscle vessels with Alcian Blue 8GX provided evidence of an MPO-dependent decrease in anionic charge of the EG. MPO binding to the glycocalyx was further characterized using Chinese hamster ovary cells and its glycosaminoglycan mutants-pgsA-745 (mutant Chinese hamster ovary cells lacking heparan sulfate and chondroitin sulfate glycosaminoglycan) and pgsD-677 (mutant Chinese hamster ovary cells lacking heparan sulfate glycosaminoglycan), which revealed heparan sulfate as the main mediator of MPO binding. Further, EG integrity was assessed in terms of thickness using intravital microscopy of murine cremaster muscle. A significant reduction in EG thickness was observed on infusion of catalytically active MPO, as well as mutant inactive MPO and cationic polymer polylysine. Similar effects were also observed in wild-type mice after a local inflammatory stimulus but not in MPO-knockout mice. The reduction in EG thickness was reversed after removal of vessel-bound MPO, suggesting a possible physical collapse of the EG. Last, experiments with in vivo neutrophil depletion revealed that MPO also induced neutrophil-mediated shedding of the EG core protein, Sdc1 (syndecan-1). Conclusions- These findings provide evidence that MPO, via ionic interaction with heparan sulfate side chains, can cause neutrophil-dependent Sdc1 shedding and collapse of the EG structure.
- 650 _2
- $a břišní svaly $x krevní zásobení $7 D000009
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a CHO buňky $7 D016466
- 650 _2
- $a kationty $7 D002412
- 650 _2
- $a Cricetulus $7 D003412
- 650 _2
- $a endoteliální buňky $x účinky léků $x metabolismus $x patologie $7 D042783
- 650 _2
- $a glykokalyx $x účinky léků $x metabolismus $x patologie $7 D019276
- 650 _2
- $a heparansulfát proteoglykany $x metabolismus $7 D019812
- 650 _2
- $a endoteliální buňky pupečníkové žíly (lidské) $x účinky léků $x metabolismus $x patologie $7 D061307
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši inbrední C57BL $7 D008810
- 650 _2
- $a myši knockoutované $7 D018345
- 650 _2
- $a aktivace neutrofilů $7 D018375
- 650 _2
- $a neutrofily $x účinky léků $x metabolismus $7 D009504
- 650 _2
- $a peroxidasa $x nedostatek $x genetika $x metabolismus $x farmakologie $7 D009195
- 650 _2
- $a vazba proteinů $7 D011485
- 650 _2
- $a syndekan-1 $x metabolismus $7 D053668
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kolarova, Hana $u Institute of Biophysics AS CR, Brno, Czech Republic (H.K., J.V., L.K.). International Clinical Research Center, St. Anne's University Hospital Brno, Czech Republic (H.K., J.V., L.K., A.K.).
- 700 1_
- $a Kerkenpaß, Christina $u From the Department of Cardiology, Heart Center, University of Cologne, Germany (K.M., C.K., M.M., V.R., S.B., M.A., A.K.). Center for Molecular Medicine Cologne, University of Cologne, Germany (K.M., C.K., M.M., V.R., S.B., M.A., A.K.).
- 700 1_
- $a Mollenhauer, Martin $u From the Department of Cardiology, Heart Center, University of Cologne, Germany (K.M., C.K., M.M., V.R., S.B., M.A., A.K.). Center for Molecular Medicine Cologne, University of Cologne, Germany (K.M., C.K., M.M., V.R., S.B., M.A., A.K.).
- 700 1_
- $a Vitecek, Jan $u Institute of Biophysics AS CR, Brno, Czech Republic (H.K., J.V., L.K.). International Clinical Research Center, St. Anne's University Hospital Brno, Czech Republic (H.K., J.V., L.K., A.K.).
- 700 1_
- $a Rudolph, Volker $u From the Department of Cardiology, Heart Center, University of Cologne, Germany (K.M., C.K., M.M., V.R., S.B., M.A., A.K.). Center for Molecular Medicine Cologne, University of Cologne, Germany (K.M., C.K., M.M., V.R., S.B., M.A., A.K.).
- 700 1_
- $a Kubala, Lukas $u Institute of Biophysics AS CR, Brno, Czech Republic (H.K., J.V., L.K.). International Clinical Research Center, St. Anne's University Hospital Brno, Czech Republic (H.K., J.V., L.K., A.K.).
- 700 1_
- $a Baldus, Stephan $u From the Department of Cardiology, Heart Center, University of Cologne, Germany (K.M., C.K., M.M., V.R., S.B., M.A., A.K.). Center for Molecular Medicine Cologne, University of Cologne, Germany (K.M., C.K., M.M., V.R., S.B., M.A., A.K.). Cologne Cardiovascular Research Center, University of Cologne, Germany (K.M., S.B., A.K.).
- 700 1_
- $a Adam, Matti $u From the Department of Cardiology, Heart Center, University of Cologne, Germany (K.M., C.K., M.M., V.R., S.B., M.A., A.K.). Center for Molecular Medicine Cologne, University of Cologne, Germany (K.M., C.K., M.M., V.R., S.B., M.A., A.K.).
- 700 1_
- $a Klinke, Anna $u From the Department of Cardiology, Heart Center, University of Cologne, Germany (K.M., C.K., M.M., V.R., S.B., M.A., A.K.). Center for Molecular Medicine Cologne, University of Cologne, Germany (K.M., C.K., M.M., V.R., S.B., M.A., A.K.). International Clinical Research Center, St. Anne's University Hospital Brno, Czech Republic (H.K., J.V., L.K., A.K.). Cologne Cardiovascular Research Center, University of Cologne, Germany (K.M., S.B., A.K.).
- 773 0_
- $w MED00000590 $t Arteriosclerosis, thrombosis, and vascular biology $x 1524-4636 $g Roč. 38, č. 8 (2018), s. 1859-1867
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29903730 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20191010105030 $b ABA008
- 999 __
- $a ok $b bmc $g 1451847 $s 1073737
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 38 $c 8 $d 1859-1867 $e - $i 1524-4636 $m Arteriosclerosis, thrombosis and vascular biology $n Arterioscler Thromb Vasc Biol $x MED00000590
- LZP __
- $a Pubmed-20191007